Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus

Last updated: June 8, 2023
Sponsor: Sohag University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Musculoskeletal Diseases

Cutaneous Lupus Erythematosus

Lupus

Treatment

Anti _KU antibodies

Clinical Study ID

NCT05900232
Soh-Med-23-05-05MD
  • Ages 17-60
  • All Genders

Study Summary

systemic lupus Erythematosus (SLE) is a multi system autoimmune disorder abroad spectrum of clinical presentations.

Diagnosis of SLE depending on Systemic Lupus International Collaborating Clinics (SLICC) Criteria.

SLICC Criteria requires either that a patient satisfy at least 4 of 17 Criteria including at least 1 of 11 clinical criteria and 1 of 6 immunological criteria or the patient has biopsy -proven nephritis compatible with SLE in the presence of antinuclear antibodies (ANA)or anti_double stranded DNA (dsDNA) antibodies.

Anti_KU antibodies included in (ANA), reported in many autoimmune disorders like SLE,Sjogren syndrome, idiopathic lung fibrosis and myositis.

So the aim of the work is to determine the relationship between Anti_KU antibodies and SLE manifestations.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • all patients will fulfill the Systemic Lupus International Clinics(SLICC)classification criteria for Systemic Lupus Erythematosus.

Exclusion

Exclusion Criteria:

  • any patient with any collagen disease other than SLE

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Anti _KU antibodies
Phase:
Study Start date:
May 15, 2023
Estimated Completion Date:
November 01, 2023

Connect with a study center

  • Sohag University Hospitals

    Sohag,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.